Stock Comparison

ARGX vs AXSM

argenx NV ADR and Axsome Therapeutics Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

AXSM

Axsome Therapeutics Inc

Healthcare

Valuation

Market Cap

$55.44B

$12.44B

P/E (TTM)

39.4

—

Forward P/E

34.0

333.3

Price/Sales

11.7

17.6

Price/Book

7.5

227.8

EV/EBITDA

33.9

-14.8

Dividend Yield

—

Profitability

Net Margin

31.40%

-26.60%

Operating Margin

30.00%

-32.80%

Return on Equity

20.20%

-349.40%

Return on Assets

8.86%

-16.80%

Growth (YoY)

Revenue Growth

62.60%

57.40%

Earnings Growth

114.00%

0.00%

Price & Risk

Beta

-0.0

0.6

52-Week High

$934.62

$260.19

52-Week Low

$510.06

$96.09

Analyst Target

$1,041.14

$276.47

Compare ARGX and AXSM your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.